Searchable abstracts of presentations at key conferences in endocrinology

ea0049s13.3 | Challenging pituitary diseases | ECE2017

Imaging of sellar masses

Buchfelder Michael

To date, magnetic resonance tomography is generally considered the imaging method of choice for its premium resolution of lesions and surrounding anatomic structures. This is mainly due to the improved soft tissue contrast this method offers. Other advantages are the possibility of direct multiplanar imaging in sagittal, coronal, and axial orientations and the avoidance of ionizing radiation. The goal of all imaging studies in this region is to indicate precisely the location,...

ea0047oc17 | Spotlight on Neuroendocrine tumours | Theranostics2016

Dosimetry in 177Lu treatment: what we know and what we do not know

Lassmann Michael

177Lu-labelled compounds show many advantages for dosimetry assessments due to the attractive physical properties of the isotope which comprise a clearly separated gamma peak at 208 keV and low abundance of photons which permits reliable quantitative imaging after therapy. In addition, the low range of beta particles is advantageous for radiation protection. This talk mainly focuses on dosimetry methodology which includes consideration of the number and time points ...

ea0047oc30 | Spotlight on Prostate Cancer | Theranostics2016

Beyond wizardry: creating high level evidence for PSMA PET Imaging and Theranostics

Hofman Michael

Ga-68 PSMA PET/CT is producing images with astounding tumour-to-background contrast for staging prostate cancer. Defining the extent of prostate cancer spread with imaging is of utmost importance for therapeutic decision-making. Relapse following curative-intent treatment is not uncommon despite careful selection of patients with CT, MRI and bone scintigraphy prior to surgery or radiotherapy, highlighting the limited sensitivity of conventional imaging. Imaging with PSMA-PET m...

ea0041s23.2 | Indications of incretin based therapies | ECE2016

GLP-1 in type 2-diabetic patients

Nauck Michael

GLP-1 is one of the two known incretin hormones (the other one being GIP), which have the ability to stimulate insulin secretion whenever glucose concentrations are above a certain permissive threshold. The incretin effect (greater stimulation of insulin secretory responses with oral as compared to matched intravenous glucose administration) is reduced in patients with type 2 diabetes, thus the question needed to be addressed, whether there is hyposecretion or impaired action ...

ea0035s16.2 | Metformin: old dog, new tricks | ECE2014

Mechanisms of antitumoral activity of metformin in thyroid cancer

Derwahl Michael

The relative risk associated with diabetes and obesity is significantly higher for different carcinomas including thyroid cancer. There is some evidence that insulin resistance and as a consequence hyperinsulinemia rather than hyperglycemia are responsible for the higher prevalence of cancer in diabetic and obese patients. In the thyroid insulin/IGF-depending signalling is part of the mitogenic pathways that regulate benign and malignant growth. In diabetics with hyperinsuline...

ea0032s2.2 | Cushing's Disease with negative pituitary imaging | ECE2013

Surgical approach to corticotroph adenomas poorly visible at preoperative imaging

Buchfelder Michael

Most pituitary operations for Cushings’s disease are technically difficult procedures. Since the souce of excessive ACTH-secretion in Cushing’s disesase is almost invariably a pituitary microadenoma, selective resection of this minute tumor is considered the primary standard therapy. However, almost half of the tumors escape direct preoperative detection even by sophisticated magnetic resonance imaging. Thus, in these the indication for surgery is based on laboratory...

ea0029pl7 | Diabetes as a gut disease | ICEECE2012

Diabetes as a gut disease

Nauck Michael A.

Gastric inhibitory polypeptide (GIP) is a physiologically important incretin hormone secreted from K cell of the upper small intestine. Glucagon-like peptide 1 (GLP-1) is secreted from L cells in the lower small and large intestine. Both hormones are released after nutrient (especially carbohydrate and fat) ingestion and glucose-dependently augment insulin secretion. An involvement of either incretin hormone in the pathogenesis of diabetes may, in principle, be related to abno...

ea0028pl5 | Society for Endocrinology Jubilee Medal Lecture | SFEBES2012

Acromegaly - improving outcomes

Sheppard Michael

Acromegaly is associated with increased morbidity and premature mortality (predominantly due to vascular disease), but these effects can be reduced if GH levels are controlled (<2.5 µg/l) and IGF-1 levels are normalized. Confounding pituitary hormone deficiencies, particularly ACTH deficiency (with higher doses of hydrocortisone replacement) may have a detrimental effect on outcome in patients with pituitary disease. Pituitary radiotherapy is a further factor that has...

ea0021s8.1 | Role of the circadian clock in endocrinology | SFEBES2009

Molecular basis of the circadian clock: regulation of endocrine rhythms

Hastings Michael

Circadian rhythms are cycles of behaviour and physiology that persist with a period of approximately (circa-) one day (-dian) when an individual is held in temporal isolation. They permeate all levels of biological activity, from gene expression and hormone secretion to cognitive ability. These daily rhythms are co-ordinated by a hypothalamic pacemaker, the suprachiasmatic nuclei (SCN). Individual SCN neurons are competent circadian pacemakers, synchronised to solar time by re...